Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer

30 Oct 2021

Abstract excerpt

This study aims to explore the clinical implications and potential mechanistic functions of CCR5 in triple negative breast cancer. Briefly, we demonstrated that CCR5 is overexpressed in TNBC and is associated with better prognosis of TNBC. CCR5 expression is positively correlated with tumor immune cell infiltration and tumor immune response related pathways. Multi-omics data analyses identified CCR5 associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34717291
DOI: 10.18632/aging.203654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancerPMID 34717291Read ↗

CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysisSemantic proximity Read ↗

The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancerSemantic proximity Read ↗

An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune MicroenvironmentSemantic proximity Read ↗

Exploration of prognostic value and underlying mechanism of P2RY14 in triple negative breast cancer by multi-omicsSemantic proximity Read ↗

An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancerSemantic proximity Read ↗

Pan-Cancer Analysis and Validation of NT5DC2: Emphasizing Its Prognostic Significance and Immunological Role in TNBCSemantic proximity Read ↗

Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving PathwaysSemantic proximity Read ↗

CT-based machine learning radiomics predict CCR5 expression level and survival in ovarian cancerSemantic proximity Read ↗

CCR4-NOT Transcription Complex Subunit 7 (CNOT7) Protein and Leukocyte-Associated Immunoglobulin-like Receptor-1 in Breast Cancer Progression: Clinical Mechanistic Insights and In Silico Therapeutic PotentialSemantic proximity Read ↗

Identification of DDIT4 as a Potential Prognostic Marker Associated with Chemotherapy and Immunotherapy Response in Triple-Negative Breast CancerSemantic proximity Read ↗

Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerSemantic proximity Read ↗

Performing Data Mining to Explain the Correlation between the BIRC5 Gene and Prognosis in Breast Cancer PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.